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Nicotine exposure during the onset of adolescence (periadolescence) is demonstrated to 
sensitize the brain to the rewarding effects of various drugs of abuse.  Nicotine enhances the 
expression of the transcription factor ΔFosB that may facilitate this process.  It is suggested that 
microglia, the resident immunocompetent cells in the brain, may contribute to this sensitization.  
This study was conducted to determine whether suppression of inflammatory microglia impacts 
nicotine’s ability at periadolescence to induce sensitization to cocaine in the adult rat.  To 
achieve this, minocycline was administered at a dose of 30 mg/kg, 30 minutes prior to 10 once-
daily doses of 0.4 mg/kg nicotine during periadolescence (postnatal days 35-44) in male Sprague 
Dawley rats.  FosB-like immunoreactivity (FosB-ir) in key brain reward and memory areas, and 
conditioned place preference (CPP) were used to assess changes at the molecular and behavioral 
levels.  Nicotine enhanced FosB-ir the dentate gyrus (DG) of hippocampus by 52% over vehicle 
control, while minocycline pretreatment attenuated the density of FosB-ir neurons in the DG by 
34% compared to nicotine at PND 45.  Similar, but not statistically significant reductions were 
observed in the nucleus accumbens (NAc), and medial prefrontal cortex (mPFC).  This trend 
continued when the rats were allowed to mature into adulthood (PND 80) in both the NAc and 





compared to nicotine in the mPFC.  The significant reduction in FosB-ir observed at PND 45 in 
the DG with minocycline pretreatment was reversed at PND 80.  CPP studies indicated that both 
nicotine and minocycline-prior-to nicotine enhanced the rat’s anticipation for challenge cocaine 
following adult conditioning by over 100% with no significant difference between the two.  
These results suggest that nicotine-induced inflammatory (M1) activation of microglia may be 
important for the induction of FosB protein, but not related to the sensitization of the adult rat to 
cocaine.  The results further suggest a mechanism separate from induction of FosB expression in 
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Chapter 1:  Problem Description 
 The epidemic of psychoactive drug abuse is a world-wide phenomenon that is 
burdensome not just to individuals and families, but to nations as a whole.  Pathologies due to 
drug abuse result in elevated healthcare spending, untimely deaths, as well as losses in 
productivity.  Drug use can occur at any age during an individual’s lifespan, but exposure during 
adolescence is especially critical as the brain is undergoing structural and neurochemical 
plasticity in preparation for adulthood (Kandel 1975, Arain et al. 2013).  Drug exposure during 
this time of rapid plasticity increases the probability of an individual becoming substance-
dependent, or vulnerable to the rewarding effects of psychoactive substances in the future, a 
process referred to as ‘sensitization’ (Robinson and Berridge 2008).  It is currently understood 
that the underlying bases for this effect are persistent structural and neurochemical changes that 
alter the subject’s perception of psychoactive substances during the life of the individual.  During 
this period, changes occur in the brain that increase the abuse liability of psychoactive 
substances, and thus sensitizes the brain in a way that makes the individual more vulnerable to 
the psychoactive effects of drugs (Kandel 1975, Kandel and Kandel 2014).   
 Nicotine, named after Nicotiana tabacum tobacco plant, is a psychoactive substance that 
is commonly available in tobacco-laced products and is conducive to enhancing sensitization in 
the brain (Koob et al. 2014).  Although tobacco smoking has declined, nicotine continues to be 
widely accessed in the form of E-cigarettes (E-cig) or vaporizers by adults and teenagers.  
Nicotine use is widespread among the youth, not just in the United States, but world-wide.  
National data from the Youth Risk Behavior Surveillance (YRBS) system for 2015 indicate that 
youths in grades 9-12 on at least one day during the previous 30 days had smoked cigarettes 





31.4% subjects had used one of these nicotine containing products.  Further, 6.6% reported 
smoking a cigarette before age 13 (Arrazola et al. 2015).  Clearly, tobacco and nicotine in 
vaporizers remain one of the most commonly abused drugs during the developmental period of 
adolescence.  We and others, believe that this use is not without consequences.  A 2012 survey 
conducted among US adults indicated that a large percentage of cocaine users (87.9%) used 
tobacco products prior to using cocaine (Kandel and Kandel 2014).  This highlights the need to 
better understand how nicotine exposure during adolescence reorganizes the brain so that 
molecular targets can be further identified and therapeutic novelties to curb the brain’s 
















Chapter 2: Literature Review 
2.1 Gateway Hypothesis   
Adolescence is a vulnerable time for brain development as a child transitions into an adult.  
During this critical period, the brain is undergoing maturation that is partly driven by changes in 
pubertal hormone levels.  Perturbations during this vulnerable time window could result in long-
lasting neuronal maladaptations that can alter an individual’s behavior as an adult, or the way the 
individual responds to changing circumstances.  The development of reward sensitivity is one 
such example.  Exposure to drugs of abuse such as nicotine during adolescence can cause 
alterations in neuronal pathways that sensitize the brain so that it responds differently to 
psychoactive drug stimuli in the future.  More importantly, an individual may develop a 
predisposition to experimenting with or abusing psychoactive substances in the future due to the 
development of persistent neuronal modifications resulting from previous experiences (Adriani 
et al. 2003, Casey et al. 2008).  This ‘development of predisposition’ is an example of the 
‘Gateway’ hypothesis of drug abuse (Kandel 1975).  The concept is that adults who are addicted 
to powerful drugs such as cocaine or narcotics are likely to have started their journey as pre- or 
early teen-agers with drugs or substances that are inexpensive and available to the youth of that 
age.  In addition to nicotine from tobacco and vaporizers, the youth can access alcohol, 
marijuana, and other cheaply accessible products that can be used for experimentation, leading 
some to progress on to more dangerous and potent drugs.  Thus, it is important to understand 
why the early adolescent is vulnerable to these gateway drugs and the altered neuronal functions 







2.2 Vulnerability of brain during adolescence 
During adolescence, the brain is vulnerable to perturbations by drugs and toxins, as the 
foundation is being laid for the refinement of neuro-behavioral circuits, especially those 
pertaining to sexual and social behaviors (i.e. maturation, Schulz and Sisk 2006).  This window 
of development is characterized as a time for impulsivity, sensation-seeking, and 
experimentation (i.e. risk taking, Spear 2000).  Many anatomical and physiological changes are 
occurring in the brain during this window that promote plasticity, or the ability of the brain to 
change or adapt, and this expectedly manifests into alterations of behavior (Arain et al. 2013).  
During this transitional epoch, the brain is not necessarily changing in volume, but in its 
organization.  Different brain nuclei are maturing at different rates.  Maturation typically 
commences with modifications of phylogenetically older circuits such as the limbic system, 
followed by maturation of circuits of the frontal and parietal cortex that are associated with 
impulse control and executive functioning (Gogtay et al. 2004, Yuan et al.2015).  The 
differential maturation of the limbic system, which includes the reward system, compared to that 
of frontal cortical systems is believed to be responsible for the impulsive behaviors observed in 
adolescents.  Concurrent synaptic pruning and strengthening based on experience promotes the 
steady decline of gray matter and an enhancement in myelinated neurocircuitry or white matter 
as development progresses (Blakemore et al. 2010).  Changes in neurochemistry over the course 
of adolescence allow for the transition of neural connectivity from a local to a wider span, in that 
the brain progresses toward more functional integration via recruitment of working memory-
associated nuclei such as hippocampus and PFC (Fig. 2.1).  The pubertal hormones play an 
intimate role in the remodeling of circuits to modify social, sexual, and reward behavioral 





the hormonal surge (Schulz and Sisk 2006, Sato et al. 2008).  Disruption of hormonal 
functioning during puberty can alter neuronal chemistry and functioning in a way that can alter 
the brain’s responsivity to a variety of stimulants in the future (Varlinskaya et al. 2013).  In the 
adolescent brain, gonadal steroids facilitate neurogenesis, gender dimorphism, neurite outgrowth, 
and brain organization that manifest into persistent behavioral changes (Arain et al. 2013).    
2.2. A. Role of Pubertal hormones and maturation of CNS 
Adolescence starts with the onset of puberty, and is marked by the reactivation of the 
hypothalamus-pituitary-gonadal (HPG) axis.  Gonadotropin-releasing hormone (GnRH) from the 
hypothalamus stimulates the release of sex hormones that facilitates neuronal plasticity and 
sexual dimorphism (Swerdloff and Odell 1975).  Puberty in human males commences roughly by 
the age of 10 and is completed by the age of 15 with maturity of spermatogenesis (Vigil et al. 
2016).  This is commonly a time window when human teenagers expose themselves to nicotine, 
and according to Youth Risk Behavior Survey (YRBS), males are more likely to report use of 
nicotine-containing products than females (Arrazola et al. 2015).  During this period, sex 
hormones such as estrogen, progesterone, and testosterone accelerate the maturation of a 
dormant neurocircuitry that was initiated during the perinatal stage (Gillies and McArthur 2010).  
Furthermore, sex hormones activate glia that contribute to myelination of neurons by acting as 
trophic factors (Schwarz and Bilbo 2012).   
Pubertal onset is physically recognizable in males in both humans and rodents by a 
characteristic enlargement of testicles and rapid weight gain from increased food consumption 
(Soliman et al. 2014). The brains of adolescent males are enriched with androgen (AR) and 
estrogen (ER) receptors (Sato et al. 2008).  Testosterone, produced primarily in the male testis, 





reproductive behaviors in males (Sisk and Zehr 2005, Sato et al. 2008).  Testosterone is 
aromatized to estradiol via brain aromatases that further promotes masculinization of the brain 
(Wu et al. 2009).  Aromatases are prevalent in the male brain in regions such as amygdala, 
midbrain, cortex, and hippocampus (Barbieri et al. 1986, Gillies and Mc Arthur 2010).  The 
importance of estrogen in neural circuit development is highlighted by aromatase knockout 
models that display a spontaneous apoptosis of dopaminergic (DA) neurons in the medial 
preoptic area (MPOA) and arcuate nucleus of hypothalamus of male mice (Hill et al. 2004, 
Gillies and McArthur 2010), lending support to the importance of hormonal homeostasis in 
neurogenesis and DA activity.  Alterations in hormone synthesis and function due to xenobiotic 
exposure during adolescence can potentially impact plasticity, leading to aberrations in 
neurogenesis and ultimately behavior (Wu et al. 2009).  
 Exogenous influences such as drugs of abuse from different classes impact hormonal 
homeostasis and affect motivational and reward-seeking patterns.  Opiates and cocaine, for 
example, are common substances that teenagers can access, and exposure to these substances can 
profoundly impact the HPG and hypothalamic-pituitary-adrenal (HPA) axes.  Opiates such as 
methadone inhibit GnRH and DA activity in the hypothalamus and in effect reduce testosterone 
and upstream luteinizing hormone (Brown et al. 2006, Singh et al. 1982).  Opioid use can also 
result in adrenal insufficiency and hypogonadism, which are associated with depression, 
impaired cognition, and drug abuse (Brown et al. 2006).  Under in vitro conditions, nicotine, the 
drug of interest in this study, impacts the endocrine system and can alter circuit formation by 
blocking the conversion of the neuroactive androgen androstenedione to estrogen via nicotine’s 
competitive inhibition of brain aromatases (Biegon et al. 2012, Villalba et al. 1999).  Studies in 





development (Biegon et al. 2012).  Whether or not aromatase activity contributes to sensitization 
in the context of gateway drugs is unclear.   
2.2. B. Neurochemical changes make early adolescent brain vulnerable to exogenous insults 
Neurochemical changes accompany structural changes that the brain undergoes during 
adolescence to better integrate the limbic, striatal and frontal regions during this time (Depue and 
Collins 1999).  Drugs of abuse can have lasting consequences by interfering with these processes 
(Izenwasser 2005).  Dopamine is a neurotransmitter commonly associated with locomotor 
sensitization, novelty seeking, and motivated behavior (Wingo et al. 2016).  Activities that 
enhance such behaviors increase DA output in brain areas involved with the assessment of such 
activities including the ventral (NAc) and dorsal striatum (Wise 2004, Wingo et. al. 2016).  It is 
currently accepted that sensitization of these behaviors is due to an enhanced responsiveness of 
the DA system, as during the course of adolescence, dopaminergic neuronal connections in 
various nuclei such as NAc, hippocampus, and PFC become increasingly integrated to form the 
reward circuitry (Fig 2.2, Wahlstrom et al. 2010).  Radioligand-binding assays of male rat brain 
homogenates reveal increments in the densities of DA receptors (DARs), notably D1 and D2, in 
the entire striatum and PFC during early adolescence (PND 40) that are subsequently pruned at 
late adolescence (PND 60-80) in both the PFC and dorsal striatum.  In the NAc however both 
D1R and D2R densities remain relatively stable at late adolescence (Andersen et al. 2000).  The 
temporal boost in DAR activity during adolescence is thought to facilitate synaptic connectivity, 
while their further pruning during late adolescence and adulthood especially in the striatum and 
PFC, allow for dopaminergic signaling that is progressively more efficient as the adolescent 
subject transitions into adulthood (Sisk and Zehr 2005, Andersen et al. 2000, O’Donnell et al. 





During the transition from adolescence to adulthood, the DA system in the PFC is 
modified to allow for enhanced regulation of NAc functions (Yuan et al. 2015).  Plasticity during 
this time allows for inhibitory interneurons to better regulate the excitability of pyramidal 
neurons (the major output neurons) in the PFC, which in turn regulate NAc activity.  Both the 
pyramidal neurons and the regulatory GABAergic interneurons in the PFC contain D1 and D2 
receptors.  D1 receptors associate with N-methyl-D-aspartic acid receptors (NMDARs) and 
enhance their response, whereas D2 receptors associate with α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors and attenuate the AMPA response.  During early 
adolescence, the D1-NMDA as well as the D2-AMPA receptor interactions are less pronounced 
than during adulthood or even late adolescence, with the D1-NMDAR interaction taking 
prevalence over D2-AMPA interactions.  Combined, in the presence of high levels of DA as 
expected in the presence of cues associated with drug-reward, this leads to an overall enhanced 
pyramidal cell activity without adequate GABAergic regulation.  During adulthood, the D2 
mediated GABAergic signaling becomes more refined and is thus better able to regulate 
pyramidal cell activity, in effect improving the signal-noise ratio (Fig. 2.3.A, O’Donnell 2010).   
In the NAc, the same trend follows as in the PFC.  Adolescents lack the mature D1-
NMDAR and D2-AMPAR interactions, as well as GABAergic signaling that is needed for 
interneuron mediated regulation of the accumbal medium spiny neurons (MSN).  The weak 
interactions further lead to reduced interneuron excitability during adolescence, which 
progressively reverses as the individual matures into adulthood, and the D2-AMPA system is 
better able to interact with and recruit the GABA system (Yuan et al. 2015).  These changes steer 
the brain toward the ability to discriminate and weigh reward with consequences as the subject 





2.3. Neuronal effects of nicotine exposure 
 Nicotine, a sympathomimetic alkaloid that selectively binds subunits present in nicotinic 
acetylcholine receptors (nAChR), can have a significant impact on limbic circuitry that is 
undergoing plasticity during adolescence.  Nicotine’s actions on nicotinic receptors can alter the 
excitation and release of catecholamines, including DA, that integrate circuits underlying 
motivated behavior (Dwyer et al. 2009).  Nicotinic receptors mediate the actions of acetylcholine 
(ACh) that plays an important role in brain maturation and synaptic transmission by activating 
various combinations of nAChR subunits, with the most abundant being the α4β2 combination 
(Dani 2001, Dwyer et al. 2009).  Nicotinic receptors comprised of the α4 and β2 subunits are the 
primary high-affinity nicotine binding sites in the brain, and are involved in mediating nicotine 
reward, as mice null in either of the subunits do not respond to nicotine with the same efficacy as 
their wild type counterparts (Dwyer et al. 2009, Pons et al. 2008).  The α4β2 subtype is 
upregulated both during adolescence and adulthood with chronic exposures to nicotine (Doura et 
al. 2008).  Furthermore, the enhanced activity of this receptor subtypes is due to post-
translational mechanisms in rodents, not so much by increased subunit assembly or trafficking, 
but via a gradual enhancement in the stability of the subunits that allow for reductions in receptor 
turnover and desensitization with subsequent exposures to nicotine (Vallejo et al. 2005).  It is 
also reported that chronic exposure to nicotine increases the affinity of the receptor for nicotine, 
and this could further contribute to increased sensitivity to nicotine (Marks et al. 1992, Vallejo et 
al. 2005).  Intriguingly, the α4β2 subtype is also present during late adolescence, and chronic 
nicotine exposure at late adolescence does not promote heterologous sensitization in rats to 
cocaine or diazepam when challenged with these drugs during adult testing (Doura et.al. 2008, 





activity of α4β2 subtype at late adolescence the lead to reduced conditioned responsiveness at 
adulthood to challenge drugs is unclear (McMillen et al. 2005, James-Walke et al. 2007).  
 In mediating the rewarding and motivational properties of nicotine, the β2 subtype plays a 
critical role in the depolarization of the DA cell bodies in the VTA that feed into the NAc to 
mediate the rewarding effect of nicotine (Picciotto et al. 1998, Arias-Carrión et al. 2010).  In 
mouse ß2-subunit knockout models, the mice fail to self-administer nicotine in a fixed ratio 
operant paradigm.  Additionally, these mice become less sensitive to nicotine, and there is a 
reduced efflux of DA into the extracellular fluid in the NAc when measured by DA microdialysis 
from nicotine exposure (Picciotto et al. 1998).  Furthermore, the mesencephalic DA neurons 
become unresponsive to nicotine, thus lending support to β2 subunit’s involvement in nicotine 
reinforcement.   
2.4. Rat model for studying sensitization from periadolescent exposure to nicotine  
The rat system is a widely used animal model to mimic human behavior as the window 
for adolescence is comparatively shorter in rats (days as opposed to years in humans), which 
facilitates experimentation (Spear and Brake 1983).  The testosterone surge that marks the onset 
of puberty in the male rat occurs at about postnatal day (PND) 37, and by PND 45 the testes have 
descended, the male rat is rapidly gaining weight, and is able to mate with females (Dohler and 
Wuttke 1975, Spear and Brake 1983).  The specific age for adulthood is unclear, however, 
several laboratories accept PND 70 or later as a suitable time for adult testing (Adriani et al. 
2003, Spear and Swartzwelder 2014).  Adolescent rats, much like their human counterparts, 
show an increased propensity to act impulsively and seek novelty as demonstrated by elevated 





2.4. A. Behavioral effects of nicotine-induced sensitization 
 Sensitization can be assessed by a variety of methods or paradigms  in animal models. 
Behavioral paradigms for testing sensitization allow for the assessment of changes in cue-reward 
associations that characterize the subject’s motivation for obtaining reward (Robinson et al. 
2014).  In the context of nicotine priming during early adolescence, rats show enhanced 
sensitivity towards test-drugs including stimulants such as cocaine, and anxiolytics such as 
benzodiazepines during later life when primed with nicotine at early adolescence.  Behavioral 
paradigms that assess sensitization in animal models (demonstrated by heightened 
responsiveness to a sub-maximal dose of a test substance due to prior exposure to a priming 
substance) are operant conditioning, and conditioned place preference (CPP) (Adriani et al. 
2003, McMillen et al. 2005, James-Walke et al. 2007).   
 Most behavioral studies that utilize operant conditioning for testing psychoactive drug 
sensitivity make use of different schedules of reinforcement, and the tests are typically carried 
out in operant chambers where the subject performs actions necessary to obtain reinforcement.  
Actions may involve pressing a lever one time to attain reinforcement, or the requirement could 
be increased to 3 or more presses, to make attaining reinforcement less obtainable.  Enhanced 
responses with increased work requirement signify a stronger rewarding effect of the drug, 
implying sensitization (Staddon and Cerrutti 2003).  
 Conditioned place preference (CPP), on the other hand, is typically a 3-chamber 
paradigm with two conditioning chambers and a third neutral chamber where the animal is not 
subjected to treatment.  This paradigm relies on classical conditioning, where the animal or 
subject is conditioned with a test drug in a chamber that is initially less preferred.  If a test drug 





increase in preference following conditioning.  The subject’s preference for the drug-paired 
chamber as opposed to a placebo (vehicle)-paired chamber can be assessed by the time spent in 
the drug-paired chamber (Prus et al. 2009).  Studies indicate that priming of rats with nicotine 
during early adolescence increases preference (or time spent) for a chamber paired with sub-
maximal (or subthreshold) doses of DOAs such as diazepam and cocaine following conditioning.  
Furthermore, CPP allows for the measurement of total frequency of chamber entries that can be 
used to estimate locomotion (James-Walke et al. 2007, McMillen et al. 2005).   
2.4. B. Nicotine exposure:  Periadolescence vs. late/post adolescence 
 The difference between periadolescence and post (or late) adolescence in the context of 
drug-induced sensitization to other drugs of abuse becomes apparent with behavioral tests for 
sensitization.  Adriani and colleagues (2003) demonstrated that when rats are primed with 
nicotine using a schedule of once-daily for 10 days at a dose of 0.4 mg/kg during 
periadolescence, the rats increasingly self-administered nicotine i.v. by lever-pressing to operate 
an infusion pump at adulthood over different work requirements in an operant conditioning 
paradigm.  This heightened incentive-salience, or drug seeking behavior, however was 
substantially curbed when the rats were first exposed to nicotine during late adolescence, 
indicating a weakened sensitization, or responsiveness, when priming occurred at late 
adolescence (Robinson and Berridge 2008, Adriani et al. 2003).  
CPP studies indicate similar patterns for the development of sensitization with early-life 
nicotine exposure.  McMillen and colleagues (2005) demonstrated enhanced responsiveness in 
adult rats to subthreshold doses of cocaine when the rats were previously exposed to 10 once-
daily injections of 0.4 mg/kg nicotine during periadolescence.  A subthreshold dose, or a dose 





priming during periadolescence produced long-lasting changes in the brain that led the rats to 
become more susceptible to the rewarding effects of cocaine.  When the rats were primed at late 
adolescence (PND 60-69), however, this sensitization effect was diminished, and the time spent 
in the cocaine-paired chamber was like that of the vehicle-treated cohort.  The same pattern was 
observed when the challenge drug was a subthreshold dose of diazepam (James-Walke et al. 
2007).  The enhanced sensitization from priming at periadolescence as opposed to late 
adolescence imply that changes occur in the brain with periadolescent exposure that is more 
conducive to lasting sensitization. The relative lack of sensitization at adulthood due to late-
adolescent priming could be due to the enhanced feedback regulatory system between PFC and 
NAc as discussed previously. 
2.4. C. Molecular effects of nicotine-induced sensitization  
 Behavioral tests can estimate the strength or degree of development of sensitization.   
They however do not shed light into the changes occurring at the molecular and neuronal levels 
that facilitate this phenomenon.  The study by Adriani and colleagues (2003) demonstrated that 
priming with nicotine during periadolescence increased the mRNA levels of α5, α6, and ß2 
nicotinic receptor subunits in the VTAs of rat brains when analyzed at adulthood (PND 75).  
However, when a comparative group of rats were primed with nicotine during late adolescence 
(PND 60-69), there was a reversal in the mRNA levels of the aforementioned subunits compared 
to control, thus indicating an age-dependent molecular effect of nicotine exposure that 
manifested as disparate behavioral outcomes, in this case nicotine self-administration.  Changes 
in the expression patterns of nAChR subunits in the VTA, as a result of periadolescent exposure 
to nicotine, may be more conducive to plasticity in the DA signaling system in the NAc due to 





early genes (IEGs) and their downstream targets discussed later (Adriani et al. 2003, Picciotto et 
al. 1998).  The underlying molecular bases for time or age-dependent plasticity needs further 
exploration to better enable therapeutic interventions to preempt the adverse consequences of an 
individual’s future encounters with psychoactive drugs such as dependence and relapse. 
2.4. C. 1.  Significance of IEGs and FosB in facilitating long-term sensitization and memory 
   Various studies of the effects of nicotine and other psychoactive substances in animal 
models have implicated the DA system’s involvement in the rewarding properties of these drugs 
(Picciotto et al. 1998), yet how sensitization of the reward system develops from these drugs 
remains unclear.  Exaggerated responsiveness during later life to cue or stimuli that was 
associated with past experiences suggests the development of intrinsic modifications occurring at 
the cellular and molecular levels from the previous experiences (Robinson et al. 2014).  In a 
neurochemical context, studies demonstrate that immediate early genes (IEGs) from different 
families mediate plasticity via induction of plasticity-related proteins (PRPs) to enhance 
associative memory formation that can facilitate learning (Minatohara et al. 2015).  Changes in 
the levels of expression of IEGs from DOA stimulation can thus be expected to have an impact 
on long-term neuronal modifications lasting into the future that can outlast the temporary 
psychopharmacological effects observed during the time of drug exposure via synaptic 
modifications (Abraham et al. 1991).  This can further facilitate formation of memory trace and 
recall (Minatohara et al. 2015).  
  IEGs belonging to the fos family of transcription factors have gained recent notice for 
their putative roles in mediating drug reward and dependence.  In a study involving nicotine 
pretreatment followed by cocaine challenge, FosB and its spliced isoform ∆FosB, referred to by 





increasingly active during cocaine conditioning in C57BL/6J mice that were previously primed 
with nicotine.  It was further demonstrated that nicotine priming enhanced subsequent cocaine’s 
ability to inhibit histone deacetylase (HDAC) activity in the entire striatum, which led to the 
hyperacetylation of FosB promoter regions resulting in the accumulation of FosB protein.   This 
effect was accompanied by an enhanced locomotor response to cocaine (Levine et al. 2011).   
 Another study performed in rats by Soderstrom and colleagues (2007) demonstrated that 
24 hours following 10 once-daily injections of 0.4 mg/kg nicotine during periadolescence, there 
was an increase in the density of neurons expressing the protein FosB in key memory and reward 
areas of the rat brain, which included the NAc, mPFC, and dentate gyrus (DG) of the 
hippocampus.  Furthermore, this change was sustained into adulthood (PND 80), especially in 
the NAc and the DG.  Similar trends in the density of FosB-immunoreactive (FosB-ir) neurons 
were observed in the brains of the rats when analyzed 24 hours following the same injection 
schedule at late adolescence (PND 60-69, Soderstrom et al. 2007), thus indicating that FosB 
response to nicotine is not temporally dependent, but rather an accumulation of the protein from 
repeated nicotine exposure.  It is further important to mention here that the antibody used in that 
study recognized all variants of FosB protein including the stable splice variant ΔFosB.  
  ΔFosB is a transcription factor that is a product of the fosb gene and is formed by the C-
terminal truncation of full-length FosB (Fig. 2.4).  It dimerizes with c-Jun to form the AP-1 
transcription complex (Dobrazanski et al. 1991).  The AP-1 complex then binds AP-1 sites on 
promoter sequences of several target genes to induce transcription of key genes implicated in 
synaptic connectivity in brain areas associated with drug seeking and dependence (Nestler 2001).  
The C-terminal truncation of FosB confers to ΔFosB a unique stability that allows the protein to 





protein that degrades within hours of a single drug exposure (Nestler 2001).  The dimerization of 
ΔFosB with c-Jun appears to play a necessary role in the sensitization process, as selective 
deletion of c-Jun in the ventral (NAc) and dorsal striatum reduces the rewarding effects of 
cocaine (Peakman et al. 2003).  The role of FosB in mediating the rewarding and sensitizing 
properties of DOAs appears to be primarily focused in the NAc.  Furthermore, studies indicate 
that FosB may recruit the opioid system to mediate behavioral sensitization.  This was 
demonstrated in a study where ∆FosB was selectively overexpressed in the dynorphin-containing 
MSNs in the striatum of adult mice, and this resulted in increased behavioral sensitization of the 
animal to drugs of abuse such as morphine (Zachariou et al. 2006).  It is currently held that 
∆FosB enhances the activation of several down-stream target genes that may contribute toward a 
‘relative permanence’ in the brain’s sensitization to drugs of abuse (Nestler et al. 2001).  
 ∆FosB induction from repeated exposure to stimuli promotes neuronal plasticity through 
a variety of mechanisms and targets.  One important downstream target is the AMPA glutamate 
receptor subunit (GluR2).  GluR2 appears to be the only AMPA receptor subtype whose 
expression is increased in the NAc due to ΔFosB overexpression, and overexpression of GluR2 
in the NAc engenders reward phenotypes for cocaine consistent with that of ΔFosB (Kelz et al. 
1999).  Another downstream effector of ∆FosB is cdk5 (cyclin dependent kinase 5), which is 
involved with neuronal growth and survival (Bibb et al. 2001).  The inhibition of cdk5 in the 
NAc by roscovitine reduces cocaine’s ability to induce dendritic spine development in NAc core 
and shell (Norrholm et al. 2003).  Furthermore, cdk5 activity regulates dopamine and cyclic 
AMP-regulated phosphoprotein 32 (DARPP-32) phosphorylation, which plays a key role in DA 





that may pertain to drug-reward sensitization. It is further suggested that these morphological and 
functional changes may outlast the ∆FosB protein itself (Norrholm et al. 2003). 
2.5.  Involvement of microglia  
 A variety of mechanisms that may lead to the development of sensitization from DOA 
exposure at an early age have been investigated.  Which pathways are exactly responsible for 
establishing sensitization that persist into later life from early adolescent exposure to DOAs is 
still unclear, although FosB activation appears to play a key role (Nestler et al. 2001).  
Furthermore, whether FosB acts solo or in concert with other factors is currently of interest, as 
FosB modulates several downstream genes that regulate dopamine in memory and reward-
related circuits (Grueter et al. 2013).  Since FosB appears to be disconnected from the reward 
sensitization resulting at adulthood from early adolescent nicotine exposure (Soderstrom et al. 
2007, Adriani et al. 2003, McMillen et al. 2005), other factors that could contribute to this 
sensitization effect need to be investigated.  Microglia, the resident immunocompetent cells in 
the brain, have received attention in the attempts to understand the pathways for sensitization due 
to their importance in wiring of the neuronal circuits, and could be a putative contributor to long-
term sensitization (Paolicelli et al. 2011).  Microglia display a variety of morphologies 
depending on the microenvironment (Fig. 2.5).  Additionally, microglia activation and 
involvement have been ascribed to the sensitization effect of various psychoactive substances 
such as morphine and cocaine (Schwarz and Bilbo 2013, Chen et al. 2009).   
2.5. A. Importance of microglia during adolescence 
 Microglia play key roles throughout the brain development process and are sensitive to 





are responsive to fluctuations in sex hormone levels in the brain, as they express cell surface 
receptors recognizing androgens and estrogens (Nissen 2017).  As adolescence is the transition 
from childhood to adulthood, led by gonadal hormonal surge, microglia can be expected to 
influence synaptic plasticity related to behavioral changes induced by nicotine and other drugs 
that can impact hormonal levels (Spear 2000, Peper and Dahl 2013, Biegon et al. 2012).    
 Microglia activity is crucial for neuronal connectivity and is intimately involved in the 
pruning of synapses by acting as highly motile phagocytes (Kabba et al. 2018).  In recent years, 
errant microglia activity has been implicated in pathologies such as Alzheimer’s and Parkinson’s 
diseases, where they are involved in cytokine secretion, and subsequent neuroinflammation in 
response to pathogen accumulation (Tejera and Heneka 2016).  Such actions often lead to 
apoptosis and phagocytosis of neurons that result in removal of dopaminergic and cholinergic 
neurons.  In the context of drug sensitization that is a form of associative learning, there is the 
possibility that activation of microglia can lead to the pruning of synapses that can consequently 
strengthen long-term cue-reward associations, which may further impact reward motivation or 
salience (Schwarz and Bilbo 2013, Robinson and Berridge 2008).  Chronic stimulation of DARs 
on microglial surface, as expected with chronic exposures to nicotine in rodents, is reported to 
enhance microglial migratory activity (Färber et al. 2005).  Microglia’s role in memory 
consolidation and learning is further highlighted by a study on the adult transgenic mouse brain 
in which depletion of microglia led to a weakening of synapses in the motor cortex that are 
normally associated with learning tasks (Parkhurst et al. 2013).  
2.5. B. Microglia Functions 
 Perturbations in microglia activity during development are linked to defects in the wiring 





2017).  Microglia intimately regulate synapses and are sensitive to neuronal signals.  Exposure of 
microglia to pathogens during critical periods of developments result in priming of microglia that 
is further exacerbated by later exposure to same or different pathogens, an indication of 
formation of ‘microglial memory’.  This can further instigate excessive pruning of circuitry 
relevant to learning and memory, and neuroinflammation characteristic of autism-like symptoms 
(Williamson et al. 2011).  Several molecules facilitate microglia’s ability to prune leading to 
synaptic plasticity.  One example is the neurotrophic factor BDNF, the deletion of which leads to 
deficits in learning and synaptic remodeling associated with learning (Parkhurst et al. 2013).  
 Microglia express various receptors for complement proteins and immunogens on their 
outer surfaces that regulate microglia-neuron interactions.  Microglia express pattern recognition 
receptors that sense pathogen-associated molecular patterns (PAMPs) and damage-associated 
molecular patterns (DAMPs) that allow microglia to prime and react efficiently to noxious 
stimuli, one example being the Toll-like receptors (TLRs).  Under physiological conditions, 
neuron-microglia interactions via signaling molecules such as fractalkine and its receptor 
(CX3CR1), as well as other anti-inflammatory cytokines, neurotrophins, and prostaglandins 
secreted by neurons keep microglia in a relatively benign surveilling state rather than an 
activated (cytotoxic) state (Kabba et al. 2018).  Pathogens and other factors, including cytokines 
and neurotrophins, promote activation of microglia that can be either pro- or anti-inflammatory 
depending on context and severity of insult (Kabba et al. 2018).  
2.5. B. 1. Microglia polarization 
 The polarization or shifting in function of microglia appears to play a key role in the 
induction of drug sensitivity as agents selective for certain polarizations can impact the 





Bilbo 2013).  Since microglia are sensitive to their surroundings, the cells can polarize into the 
basic M1 (proinflammatory) or M2 (anti-inflammatory) classification or in between to react to 
stimuli or changes in the microenvironment.  M1 polarization typically results from actions of 
pathogens such as lipopolysaccharides (LPS) on Toll-like receptors (TLRs) that further promote 
the secretion of proinflammatory cytokines such as TNF-α, IL-1ß, interferon-γ (IFN- γ), nitric 
oxide (NO), as well as cell surface antigens CD68 and CD86 to name a few (Crews et al. 2017).  
M2 polarization is induced by molecules that promote interleukin-4 (IL-4) or IL-13 cytokines 
that direct microglia to play a role in repairing damaged tissue (Kabba et al. 2018).  As certain 
agents can induce a particular polarization of microglia, there are also agents that can inhibit 
polarization patterns.  Kobayashi and colleagues (2013) demonstrated in vitro that the 
tetracycline antibiotic minocycline selectively prevents the M1 polarization of mouse cortical 
microglia via inhibition of the transcription factor NFκB.  Furthermore, the same study 
demonstrated that minocycline did not affect the expression of molecular markers characteristic 
of M2 polarization such as CD206, arginase 1, IL-4, IL-10, and Ym-1 following LPS 
stimulation.  Thus, minocycline provides a useful tool for exploring how inflammatory 
polarization of microglia can impact sensitization of the brain by drug priming. 
2.5. B. 2.  DOAs and microglia 
 The question of whether or not DOAs can activate microglia to mediate sensitization is 
under continued investigation.  Several studies suggest that microglia may play a role in the 
process as they are impacted by drugs of abuse from different categories.  One report 
demonstrated that rats exposed to alcohol at binge levels 3 times/day for 4 days resulted in 
microglia displaying an activated morphology in the hippocampus that lasted for an entire month 





early adolescence, microglia play a role in reinstatement of sensitization to morphine following 
abstinence from initial challenge doses of morphine during later life.  In that study, ibudilast was 
used to suppress the activation of microglia during the abstinence phase, and this led to an 
inhibition of morphine reinstatement. The authors further concluded that the mechanism for 
activation of microglia due to morphine was microglial TLR4 activation as PCR experiments 
demonstrated an increase in TLR4 mRNA levels in microglia isolated from adult brains 
(Schwarz and Bilbo 2013).  
 Microglia polarization may also play a role in the brain’s sensitization to DOAs such as 
cocaine and methamphetamine.  A study performed in adult mice suggests that the activation of 
microglia may mediate locomotor-sensitization to cocaine, although microglia were not directly 
implicated in the establishment of sensitization.  In that study, minocycline at a prophylactic dose 
of 40 mg/kg administered 3 hours prior to 10 mg/kg cocaine over 4 days impaired cocaine’s 
ability to stimulate locomotor hyperactivity with later cocaine challenge.  This effect of 
minocycline was however negated once sensitization to cocaine had already been established, a 
result indicating microglia action in conjunction with cocaine in inducing locomotor sensitization 
(Chen et al. 2009).  Since minocycline selectively inhibits M1 polarization of microglia without 
impacting M2 polarization, (Kobayashi et al. 2013), it appears that M1 microglia plays a role in 
synaptic remodeling in drug-associated learning and memory formation.  Whether or not 
minocycline has an impact on curbing periadolescent nicotine-induced sensitization leading to 
cocaine-seeking at adulthood is unclear and therefore this dissertation project was designed to 







2.6. Significance, innovation, and hypothesis 
 From several studies, it appears that the M1 activation of microglia contributes to the 
psychoactive effect of various DOAs, as sensitization whether locomotor or reward, was 
inhibited with agents known to suppress M1 polarization (Chen et al. 2009, Schwarz and Bilbo 
2013).  Studies further indicate that activation of microglia occurs with exposure of laboratory 
animals to drugs of abuse such as alcohol, cocaine, and morphine (McClain et al. 2011, Guo et 
al. 2015, Schwarz and Bilbo 2013).  No study to our knowledge have demonstrated whether 
nicotine activates microglia in the context of nicotine-induced cross sensitization to heterologous 
classes of psychoactive substances.  Furthermore, there is no comprehensive understanding of 
the modifications persisting into adulthood that may enhance a subject’s vulnerability to seeking 
psychoactive drugs in the future due to periadolescent exposure to nicotine.  As discussed 
previously, the induction of FosB, the putative ‘sustained molecular switch for addiction’, is not 
confined to a specific time window for nicotine exposure (Nestler et al. 2001, Soderstrom et al. 
2007), thus necessitating the exploration of other factors that can facilitate FosB activity.  
Microglia is a likely candidate as they are reactive to the androgen surge that is expected at 
adolescence onset in males (Nissen et al. 2017).  Also, the suppression of inflammatory 
microglia activity during early adolescence curbs the reinstatement effect of DOAs such as 
morphine during adulthood when the rats were initially morphine-primed at adolescence, thus 
raising the question if microglia can also mediate sensitization from nicotine exposure during the 
onset of adolescence.   
This study aims to determine whether nicotine exposure during periadolescence promotes 
M1 activation of microglia in the brains of rats leading to lasting sensitization.  To demonstrate 





nicotine schedule of 10 once daily injections of nicotine for the 10 days bracketing the onset of 
adolescence.  For injection and analysis schedule please see (Fig 2.6).  With minocycline, the 
role of M1 microglia in promoting nicotine-induced plasticity that translates into behavioral 
vulnerability to drugs of abuse (cocaine) in the future can be better understood.  To test the 
effectiveness of minocycline, microglia activation will be assessed using morphologies 
characteristic of activated or ramified microglia, following Iba1 immunodetection.  Iba1, or 
ionized calcium-binding adapter molecule 1, is an antigen that is uniquely expressed by 
microglia throughout their cell-surface, including processes (Ito et al. 1998).  Reductions in 
density of Iba1 stained microglia displaying an ‘activated’ morphology would indicate efficacy 
of minocycline pretreatment (Fig. 2.5).  The impact of minocycline on nicotine-induced 
sensitization at the molecular level will be evaluated by relative FosB-ir, both during early 
adolescence (PND 45) and adulthood (PND 80) in the NAc, DG of hippocampus and the PFC, 
three brain nuclei involved in memory and reward perception (Soderstrom et al. 2007).  
This dissertation study will attempt to answer the following questions: (1) Does 
neurotoxic (M1) activation of microglia play a role in sensitizing the brain’s reward and 
motivation system that is stimulated by nicotine exposure during the onset of adolescence?  This 
will be assessed at the molecular level by suppressing the M1 activation of microglia with 
minocycline pretreatment 30 minutes prior to the periadolescent nicotine schedule discussed 
previously, (PND 35-44), and then immunostaining rat brain sections for FosB 24-hours (PND 
45) and 35 days (PND 80) after the final set of injections.  If FosB-ir is attenuated in minocycline 
pretreated rats, then one can infer that M1 activation of microglia does mediate FosB activity, as 
induction of FosB is both a short and long-term consequence of periadolescent nicotine exposure 





periadolescent nicotine exposure mediates heterologous-sensitization to other psychoactive 
compounds at adulthood, leading to the second question: (2) Does minocycline pretreatment 
prior to each nicotine exposure during the periadolescence window attenuate heterologous-
sensitization to cocaine at adulthood?  CPP experiments with cocaine conditioning will 
determine whether nicotine-only rats are more anticipatory of cocaine reward than the rats that 
have received the minocycline pretreatment.  Furthermore, if the suppression of M1 activation 
microglia has negligible impact on nicotine’s ability to induce FosB-ir, and there is responsivity 
to cocaine similar to that of the nicotine group, then it can be inferred that periadolescent 
nicotine enhanced sensitivity to cocaine at adulthood is independent of the M1 activation. 
2.7. Possible outcomes from this study 
  This study which combines CPP and molecular methods can result in three possible 
outcomes that will move our understanding of the periadolescent nicotine induced sensitization 
paradigm forward.  Outcome (1):  Periadolescent 10-day nicotine injection induces 
inflammatory activation of microglia along with FosB-ir.  If this is accompanied by an increased 
preference for cocaine during adulthood, then this suggests that both M1 microglia and FosB are 
involved in promoting sensitization.  Outcome (2):  Minocycline blocks M1 activation of 
microglia, but no changes in FosB-ir.  If this result is accompanied with increased cocaine 
preference during adulthood, then neither are conducive to sensitization.   Outcome (3): 
Minocycline blocks M1 microglia, but there is the increase in FosB-ir accompanied by increase 
in cocaine preference, then we know FosB, but not microglia are important to the sensitization 







2.8. Hypothesis:  
Once daily administration of nicotine at a dose of 0.4 mg/kg i.p. during the 10 days that 
bracket the onset of adolescence in rats (PND 35-44) will induce inflammatory activation of 
microglia and increase expression of the transcription factor FosB in reward-specific brain 
regions 24-hours post final injection (PND 45), with this effect sustaining till adulthood (PND 
80).  Moreover, periadolescent nicotine will sensitize the rats at adulthood (PND 80) to 
subthreshold doses of cocaine.  Pretreatment with minocycline will weaken this sensitization via 
suppression of M1 activation of microglia and reduction in FosB-ir both during periadolescence 
and adulthood, and this will manifest as reduced sensitivity to subthreshold doses of cocaine.  
For testing this hypothesis, this dissertation study was divided into three specific aims (SA).   
SA 1:  With the use of IHC determine whether inflammatory activation of microglia contributes 
to the increase in FosB protein expression at PND 45 in select brain regions (NAc, mPFC, and 
DG) from 10 once-daily injections of nicotine during periadolescence (PND 35-44). 
a. Determine whether the densities of activated microglia (measured by counting 
microglia displaying ‘activated’ morphology following surface Iba1 
immunoreaction) and neurons that express FosB-ir protein, increase in brain areas 
associated with drug reward and memory 24 hours following the periadolescent 
nicotine injections. 
b. Determine whether minocycline pretreatment reduces the density of activated 
microglia from nicotine exposure during periadolescence, and if this treatment 
attenuates the increase in FosB-ir in the select brain regions.  
SA 2:  Determine via classical conditioning whether the inflammatory activation of microglia 





a. Use CPP to determine whether the minocycline pretreatments 30 minutes prior to 
nicotine during preadolescence reduces the time spent in cocaine-paired chamber 
during adulthood following cocaine conditioning.  
SA 3:  With the use of IHC determine whether changes in the density of microglia displaying the 
activated morphology, as well as neurons expressing FosB due to periadolescent treatments are 
sustained into adulthood (PND 80), the time when behavioral testing is performed. 
a. Determine if in rats that received nicotine at periadolescence, there is a sustained 
increase in the density of microglia displaying the activated morphology, as well as 
increased expression of FosB protein in the select brain regions when brains are 
analyzed at adulthood.  
b. Determine if minocycline pretreatment during periadolescence lead to sustained 
reduction in densities of microglia displaying activated morphology, as well as 













Fig. 2.1:  A sagittal rat brain cross section depicting nuclei of the limbic system in the brain 
pertaining to this study.  The nuclei marked are medial prefrontal cortex (or mPFC), Nucleus 
accumbens (NAc), and Dentate gyrus of hippocampus (DG).  Dashed lines indicated the regions 







































Fig. 2.2:  Figure delineating the mesolimbic reward pathway.  The two main components of the 
mesolimbic reward system are ventral tegmental area (VTA) and nucleus accumbens (NAc), 
with inputs from different nuclei.  Dopaminergic (DA) neurons (blue) from the VTA synapse 
with the medium spiny neurons (MSNs) in the NAc, as well as neurons of PFC, hippocampus, 
and amygdala (AMG).  The PFC, hippocampus, and AMG send excitatory glutamatergic inputs 
(green) to the MSNs of the NAc.  The NAc in turn send GABAergic projections to the VTA.  
Nicotine primarily acts on the β2 subunits in the VTA in combination with α4, α6 subunits of the 
nicotinic receptor and increases DA levels via increasing the firing rate by producing phasic 
































Fig. 2.3: Figure illustrating the adolescent to adult transition in the PFC and NAc.  The 
interaction between the PFC and NAc become more integrated as the subject transitions from 
early to late adolescence or adulthood.  The communication between the NAc and PFC becomes 
more refined as the subject ages.  (A)  During periadolescence, the synergistic association 
between D1R and NMDA receptors produce an enhanced pyramidal cell firing, while the D2 
AMPA response is under construction.  Furthermore, the GABAergic interneurons (red) that 
suppress spurious excitation of the pyramidal neurons are still under development.  Result of this 
effect is higher background of excitatory signals to the NAc.  At late adolescence, the D2 AMPA 
activity is heightened in the pyramidal cells with enhanced GABAergic interneuron activity 
resulting in enhanced regulation of the excitatory outputs of pyramidal neurons and a more 
refined signal emanating from the PFC.  (B)  In the NAc, similar trends are observed.  Primary 
DA source to the NAc is the VTA.  Periadolescents also lack the mature D1-NMDA and D2-
AMPA receptor interactions, initially resulting in immature synaptic communication with the 
PFC.  Additionally, cell excitability of medium spiny neurons (MSN) is low due to weaker DA-
excitatory neurotransmitter interactions.  As the subject ages, GABAergic interneurons are better 
able to refine the excitability of the MSNs thus allowing the accumbal MSNs to respond more 
efficiently to PFC inputs.  Figure adapted from Yuan and colleagues (2015), and O’Donnell 















Fig. 2.4:  Figure delineating the difference between full-length FosB and it’s spliced variant 
ΔFosB.  Both moieties contain a DNA binding domain and dimerization domain that allow both 
isoforms to associate with Jun factors to form the AP-1 transcription complex.  The full-length 
FosB contain two domains that allow for proteosomal and non-proteosomal degradation.  The 
truncation of these two domains allows ΔFosB enhanced stability.  The ΔFosB isoform is smaller 
in size from the full length variant by 101 amino acids (aa).  Furthermore, phosphorylation at aa 
site S27 by casein kinase 2 (CK2) and at site S17 by other kinases confer structural stability to 

































Fig. 2.5:  Illustrations depicting characterization of microglia based on morphological features. 
A. Amoeboid microglia tend to have a larger cell body without processes.  Ramified microglia 
have small to midsize cell bodies, and thin processes.  Reactive microglia have distorted cellular 
shapes and may contain a few thickened processes.  Activated microglia have thicker and fewer 
processes, with less branching as compared to ramified.  B.  A sample immunohistological Iba1 
stain of rat brain section showing microglia morphologies in the NAc at 200X magnification.  
Larger arrows indicate reactive microglia, while arrowhead shows ramified microglia.  Scale bar 
























Fig. 2.6: Timeline for experimentation.  Male rats are obtained from Charles River, initially 
weaned (i.e. separated from dam) between post-natal days (PND) 20-22.  At PND 30, the 
Sprague Dawley rats arrive, and are pair-housed.  Rats are handled three times prior to 
commencing with injections.  On PND 35, once daily injections begin, and end at PND 44.  For 
Specific Aim1, rats are euthanized, and brains are fixed on PND 45 (24 hours after final 
injection) to examine FosB expression and microglia activation status (Iba1).  For Specific Aim 
2, same protocol is followed as in Specific Aim 1, but rats are allowed to mature to adulthood 
(PND 80) when cocaine-conditioning begins.  For Specific Aim 3, same injection protocol is 
followed as in Specific Aim 1.  Rats are allowed to mature to PND 80.  Rats are then euthanized, 


































Chapter 3:  Materials and Methods 
3.1.A. Groups and Treatment 
 Male Sprague Dawley (SD) rats were obtained from Charles River Laboratories at the 
age of PND 30.  The rats were housed in pairs under a 12-hour light/dark cycle.  Food and water 
were available ad libitum.  The rats were randomly divided into four treatment groups, namely 
vehicle (Veh), nicotine (Nic), minocycline control (Min), and minocycline 30 minutes prior to 
nicotine (NM), with n = 5-8 per group for PND 45 testing (SA 1), n = 4-5 for PND 80 testing 
(SA 3), and n = 8-12 for conditioned place preference (CPP) studies (SA 2) (please refer to Fig. 
2.5 for experimental timeline).  Nicotine hydrogen tartrate (Sigma; 0.4 mg/kg as the free base), 
saline, or minocycline-HCl (PCCA, USA; 30 mg/kg as the free base) were injected 
intraperitoneally (i.p.) once every 24 hours for a 10-day period during the light cycle from PND 
35-44.  The weights of the rats were used to determine the volume to be injected.  Rats were 
sacrificed at either PND 45, or allowed to mature till PND 80 without any treatment during the 
interim period for adult brain analysis and CPP testing.  All procedures for testing rat behavior 
and brain isolation were approved in advance by the East Carolina University Institutional 
Animal Care and Use Committee and complied with the Guide to the Care and Use of 
Laboratory Animals from the National Research Council. 
 3.1.B. Transcardial perfusion and immunohistochemistry (IHC) 
To prepare tissues for the immunodetection of FosB or microglia at PND 45 and PND 80, 
rats were first euthanized using a lethal dose of sodium pentobarbital (100 mg/kg).  Volume of 
the pentobarbital solution was adjusted so that 1 mL was appropriate for 1 kg body weight.  On 





were pumped into the left ventricle of the heart using a peristaltic pump.  Subsequently, 200 mL 
of cold buffered 4% paraformaldehyde solution was pumped into the left ventricle for systemic 
fixation of the entire animal.  Rats were then decapitated, and brains were harvested and post-
fixed overnight in 4% paraformaldehyde solution at 4oC.  The brains were then stored in 30% 
buffered sucrose solution at 4oC until sectioning.  The prepared brains were sectioned in the 
sagittal plane from 2 mm lateral-to-midline, and 40 µm sections were collected using a cryostat 
slicing in the lateral-medial direction, so that the nucleus accumbens (NAc), medial prefrontal 
cortex (mPFC), and the dentate gyrus (DG) of the hippocampus could all be visualized in the 
same section.  Sections were separated into two groups, with each group containing sections 
adjacent to that in the other group, for single antibody detection.  Free-floating sections were 
incubated in buffered 0.3 % hydrogen peroxide to quench endogenous peroxidases, followed by 
blocking in 5% normal goat serum (NGS) dissolved in phosphate buffered saline (PBS) 
containing 0.3% Triton X-100 surfactant.  Antibodies for immunodetection were directed at 
FosB (SC48: 1:1000) and Iba1 (Wako, USA: 1:10,000), an antigen commonly expressed 
throughout the surface of microglia including processes.  During the early stages of this project, 
an antibody from Santa Cruz Biotechnology (FL-147) was used to detect Iba1 expression on 
microglial cell surface.  This antibody however was not selective for microglia, as other neuronal 
types were also detected, and the antibody, and data generated from that antibody were 
consequently excluded.  Antibody selective for Iba1 was obtained from Wako, USA based on 
recommendations from various publications.  The new antibodies revealed microglia in brain 
sections that were distinctly identifiable with negligible background staining.   
Antibodies for detecting FosB were obtained from Santa Cruz Biotechnology based on 





and reacts with the shorter splice variant FosB.  Thus, what is detected is FosB-like 
immunoreactivity or FosB-ir.  Primary antibodies were further probed using the Vectastain ABC 
signal amplification kit (PK 4001, Vector Labs).  The stain was further developed using 0.05% 
diaminobenzidine (Sigma D12384) in 50 mM Tris buffer pH 7.5.  Immunolabeled sections were 
photographed using Olympus BX50 light microscope and images were analyzed with Image Pro 
software 6.3 (Media Cybernetics).  Neurons expressing FosB and microglia displaying an 
activated morphology were counted and presented as density (cells or reactive nuclei / mm2).  
Efforts were undertaken to include all treatment-groups in IHC experiments to minimize 
variance due to antibody assay conditions. 
3.1.C. Analysis of immunostained sections 
Following immunostaining of PND 45 and PND 80 rat brain sections, micrographs were 
acquired of specific brain regions associated with reward, learning, and drug seeking behavior 
(hippocampus (DG), NAc, and the mPFC) from the different treatments.  For sections assayed 
for FosB, punctate reactive nuclei in specified drawn-in areas were counted by an individual 
blinded to the treatments.  Data are presented as the number of punctate or reactive nuclei per 
unit area (mm2).  Similar procedure was followed for microglia (number of microglia displaying 
an ‘activated’ morphology’ per unit area [mm2]).  A microglial cell was deemed activated when 
the morphology of the cell presented itself as round/amoeboid, or one with thick stout processes, 
according to the classifications by Walker and colleagues (2014) (Fig. 2.4).  Images were 
acquired, and the treatment-groups were handled as uniformly as possible.  





On the data generated from both sets of experiments described previously (FosB and 
Iba1), several statistical analyses were performed to compare treatments.  One-way ANOVA was 
the primary mode of analysis with the main effects of treatment (independent variable).  
Dunnett’s t-test for multiple comparison was used for the post-hoc analysis of the ANOVA 
results.  P value < 0.05 (=0.05, 2-tailed, parametric) was deemed statistically significant.  
Furthermore, effect sizes, compared to nicotine, were calculated to analyze biological relevance.  
All statistical analyses were performed using the GraphPad Prism software or Microsoft Excel. 
3.2.A. Cocaine induced conditioned place preference (CPP) 
Periadolescent rats were treated according to the injection schedule discussed under 
3.1.A, and allowed to mature until adulthood or PND 80.  The CPP protocol followed was 
similar to that described by McMillen and colleagues (2005).  The CPP apparatus consisted of a 
three-chamber gray wooden box with distinct visual and tactile cues.  The two larger chambers, 
one black with a white circle and the other white with a black stripe, were separated by a smaller 
gray neutral chamber with guillotine doors on each side.  On days 1, 2, and 3, each rat was 
placed in the neutral chamber and the guillotine doors were lifted.  Each rat was allowed to 
explore the entire apparatus for 15 minutes.  On the 3rd day, chamber entries were recorded using 
the BEHAVIOR program (written by Prof. L.W. Means) and each rat’s chamber preference 
determined.  An entry into a chamber was scored when the rat inserted 3 paws into the chamber.  
To minimize inherent chamber bias, any rat that did not explore each chamber of the apparatus 
for at least 50 seconds per chamber on day 3 were not considered for conditioning.  On days 4, 6, 
8, and 10, each rat received an injection of 3.0 mg/kg of cocaine (cocaine-HCl as the base, Sigma 
USA, dissolved in vehicle) and then immediately confined to its less-preferred chamber for 15 





pH 6.5) and then immediately confined to its preferred chamber for 15 minutes.  On day 12, no 
injections were administered, and each rat was placed in the neutral chamber and the doors were 
lifted. Chamber-entries were again recorded for 15 minutes for each rat using the software 
BEHAVIOR.  The time spent in the least preferred chamber was recorded, as that was the 
chamber for cocaine reinforcement, as well as total chamber entries (or frequency of entry) as a 
measure of locomotion.     
3.2.B. Statistical analysis for CPP 
 On the data generated from the CPP experiments described previously, statistical 
analyses were performed to compare the differences among the treatments.  Repeated measures, 
two-way ANOVA was the primary mode of analysis with the main effects of treatment i.e. drug 
and time point (pre- vs. post- conditioning).  Bonferroni multiple comparison test was used for 
post-hoc analysis of the ANOVA results, as we are comparing before vs after or pre- vs post- 
conditioning.  A p-value  0.05 was deemed as significant.  All statistical analyses were 












Chapter 4:  Results 
4.1. Activated Microglia and FosB-ir 24 hours following periadolescent exposure 
The purpose of specific aim (SA 1) of this study was to investigate links between the 
activation of microglia and the neuronal expression of the IEG FosB measured as FosB-like 
immunoreactivity (FosB-ir) 24 hours following periadolescent nicotine exposure.  The 
tetracycline antibiotic minocycline was used to suppress the M1 (proinflammatory) polarization 
of microglia.  Adjacent sections among the four treatment groups (vehicle, nicotine, minocycline, 
minocycline 30 minutes prior to nicotine) were probed for FosB and Iba1 using selective 
antibodies.  One day following the last of 10 days of injections of nicotine at a dose of 0.4 mg/kg 
i.p. (PND 35-44), the density of activated microglia (as determined by morphology) in the NAc 
was increased by 88% when compared to the vehicle treatment group (F3,16 = 11.06, 95% CI, 
p<0.001, nicotine vs vehicle) (Fig. 4.1.5 A).  Minocycline pretreatment 30 minutes prior to each 
daily dose of nicotine reduced the density of activated microglia compared to vehicle by 6.7% 
(minocycline and nicotine vs vehicle, p>0.05), and was significantly less than the density 
observed with the nicotine group.  Minocycline control reduced the density of activated 
microglia by 13.5% (p>0.05) when compared to vehicle (Fig. 4.1.5 A).  In the mPFC, the 10-day 
exposure to nicotine increased the density of activated microglia by 82% over vehicle (F3,17 = 
5.19, 95% CI, p<0.01, nicotine vs vehicle, p<0.05), whereas in the minocycline pretreatment 
group the density of activated microglia was increased by 24% (p>0.05) when compared to 
vehicle but less than nicotine-alone by 32 % (p>0.05, Fig. 4.1.5 B).   
In harmony with a previous report (Soderstrom et al. 2007), the density of neurons 
expressing FosB-ir proteins in rats that had received ten once daily injections of 0.4 mg/kg i.p. 





were similar to the previous report (Fig. 4.1.6 E).  In the NAc, there was an 18% increase 
(p>0.05, nicotine vs vehicle) one day following the last dose of nicotine when compared to 
vehicle, but the effect did not reach statistical significance (F3,24 = 1.10, p>0.05) (Fig. 4.1.5 C).  
Furthermore, minocycline pretreatment reduced FosB-ir neurons by a modest 10% (p>0.05) from 
the nicotine group in the NAc (Fig. 4.1.5 C).   
In the mPFC, nicotine treatment increased the density of FosB-ir neurons by 32% when 
compared to vehicle (F3,19 = 1.20, p>0.05) (Fig. 4.1.5. D).  Minocycline pretreatment reduced 
density of FosB-ir neurons by 28% (p>0.05) from the nicotine group.  In the DG, nicotine 
treatment increased the density of FosB-ir neurons by 52 % over vehicle control and was 
significantly different from the other groups (F3,24 = 6.3, p<0.05) (Fig. 4.1.6 E).  Minocycline 
pretreatment reduced the density of FosB-ir neurons by 34% (p<0.05) in the DG.  In all three 
areas, the density of FosB-ir neurons in rats that had received both minocycline and minocycline-
prior-to-nicotine were less than that obtained for rats that received nicotine only.  
Effect sizes were calculated to assess biological relevance of treatments in the NAc and 
PFC (Table 4.1).  Again, only the changes in the DG were statistically significant, but the effect 
sizes of the other groups, especially in the PFC, indicate that responses were biologically 
significant. 
4.2. Conditioned place preference 
To test for changes in locomotion as a result of the treatments, the total number of 
chamber entries (entry into the three chambers) were tallied both pre- and post-conditioning 
(days 3 and 12 respectively) (Table 4.2).  There was an increase in the total number of entries 





most percent increase (73%), while the nicotine group showed a 46% increase between pre- and 
post-conditioning.  The vehicle and minocycline groups showed a modest increase of 30% pre- 
vs. post-conditioning.  There was no significant difference in changes in total number of entries 
during either pre-conditioning or post-conditioning due to the large variances.  These data 
demonstrated that the different exposures had not altered baseline activity or ‘liking’ for the 
different chambers.   
 To test for changes in responsivity of adult rats to cocaine due to the various treatment 
schedules at periadolescence, the CPP paradigm was utilized.  Minocycline pretreatment was 
used to selectively suppress the cytotoxic (M1) polarization of microglia in order to assess the 
impact of inflammatory microglia activation in facilitating the sensitization process. A dose of 
3.0 mg/kg i.p. cocaine was chosen based on previous work that examined the dose-response 
relationship for cocaine in the CPP paradigm (Jones and McMillen 1995).  The expectation was 
that this dose would be at the threshold for a significant effect.  Indeed, the vehicle group did 
demonstrate an increase of 71% (p>0.05) in the cocaine-paired chamber between pre- and post-
conditioning (Fig. 4.2.1 A).  When the time spent in the least-preferred chamber prior to 
conditioning for each rat was subtracted from the rat’s post-conditioning time, the differences 
between the exposures became more apparent (Fig. 4.2.1 B).  Both the nicotine-only and 
minocycline pretreatment groups exhibited a greater than 100% further increase in time spent in 
the cocaine-paired chamber.  An increase of 118% (p<0.05) in the difference-of-time spent in the 
cocaine-paired chamber (pre- vs post-conditioning) was observed in seconds for the nicotine 
treatment group when compared to the vehicle-only group (Fig. 4.2.1 B).  Interestingly, 
minocycline pretreatment group also showed a similar increase of 125% (p<0.05) when 





between the minocycline control group and vehicle control group, which indicates that 
minocycline alone had no impact on sensitization to cocaine (Fig. 4.2.1 A and B).  Furthermore, 
all groups on average spent an equal time in the cocaine-paired chamber prior to conditioning 
(Fig. 4.2.1 A).  
4.3. Activated Microglia and FosB-ir at PND 80 following periadolescent injection schedule 
Previously, Soderstrom and colleagues (2007) demonstrated that nicotine exposure 
during the ten days that bracket the onset of puberty in rats (periadolescence, PND 35-44) 
significantly increased the density of FosB-ir neurons in the DG, and the NAc.  Furthermore, this 
increase persisted into adulthood (PND 80).  The purpose of this study was to extend the 
aforementioned study to investigate how suppression of inflammatory microglia during 
periadolescence affects the induction of FosB in the brain of adult rats that were previously 
exposed to nicotine during periadolescence.  For this purpose, 30 mg/kg minocycline was 
administered 30 minutes prior to each 0.4 mg/kg nicotine injections once daily for the 10 days of 
periadolescence (PND 35-44).  After allowing the rats to mature to PND 80, brain sagittal 
sections from all the treatments were analyzed using IHC, with antibodies directed at FosB or 
Iba1.   
 In the NAc, Iba1 staining of PND 80 brain sections indicated that nicotine exposure 
during periadolescence increased the density of activated microglia (as determined by 
morphology) by 28% when compared to vehicle (F3,12 = 2.9, p> 0.05, nicotine vs vehicle) (Figs. 
4.3.1, 4.3.5 A).  Minocycline treatment 30 minutes prior to each daily dose of nicotine during 
periadolescence led to a decrease of 15.4% from the vehicle (minocycline-prior-to-nicotine vs 
vehicle, p>0.05) at adulthood.  The minocycline control reduced the density of activated 





A).  An unexpected observation was that the total microglia density was reduced for the 
minocycline control by 54% when compared to vehicle (F3,12 = 3.5, p>0.05, Fig. 4.3.7 A), and a 
significant reduction when compared to nicotine (p<0.05).  Nicotine and vehicle showed an 
almost identical total microglia density.  Minocycline pretreatment prior to nicotine also resulted 
in a modest decrease of 19.6% compared to nicotine-alone (p>0.05, Fig. 4.3.7 A) for total 
microglia density.  
 Similar trends in activated and total microglia density emerged in the mPFC during 
adulthood 35 days following periadolescent injection schedule.  Nicotine exposure from 
periadolescence increased the density of activated microglia during adulthood by 19.3% 
compared to vehicle (F3, 12 = 5.8, p>0.05, Figs. 4.3.2, 4.3.5 B).  Minocycline pretreatment had 
little impact on the density of activated microglia compared to the vehicle group, a reduction of 
9.6% (p>0.05), but compared to the nicotine group, the reduction was 24.2% (p>0.05).  The 
nicotine group however showed a significant increase of 31% in the density of activated 
microglia when compared to the minocycline control group (p<0.05).  The total density of 
microglia in the mPFC was consistent among the various treatments, with the exception of the 
minocycline control which showed 21% fewer microglia on average compared to the vehicle 
control (p>0.05, Fig. 4.3.7 B).  Total microglia density was significantly lower than the nicotine 
treatment group by 24.4% (F3,12 = 3.6, p<0.05, Fig. 4.3.7 B).   
In the case of FosB-ir, results obtained were in harmony with a previous report 
(Soderstrom et al. 2007) in that the once-daily for 10 days nicotine exposure increased the 
density of FosB-ir neurons in all the regions of interest, namely NAc, mPFC, and DG of the 
hippocampus (Fig 4.3.6 E).  In the NAc, periadolescent nicotine treatment increased the density 





C).  Minocycline pretreatment reduced density of FosB-ir neurons by 21.6% from the nicotine 
group (p>0.05).  In the mPFC, there was a significant increase of 96.8% in the density of FosB-ir 
neurons when compared to vehicle control (F3,16 = 4.5, p<0.05, Figs. 4.3.4, 4.3.5 D).  
Minocycline pretreatment reduced the density of FosB-ir neurons from nicotine group by 36.7% 
(p<0.05), whereas in minocycline control, FosB-ir neuron density differed from vehicle by 
51.3% (p>0.05).  Finally, in the dentate gyrus, periadolescent nicotine treatment resulted in a 
very modest increase of 15.6% (F3,16 = 0.25, p>0.05, Fig. 4.3.6 E) when compared to vehicle at 
adulthood, whereas minocycline pretreatment increased the number of FosB positive neurons in 
the DG by 12.7% (p>0.05) compared to vehicle.  Thus, the patterns were similar to the data 















Table 4.1 Effect sizes to compare the effects on FosB-ir at PND 45 by the different 
periadolescent treatment groups to nicotine control (Veh- vehicle, Nic- nicotine, Min-
































Table 2.1: Effect size (ES) calculations for FosB-reactive nuclei in the NAc and PFC (compared 
to nicotine as control).  ES< 0.3 indicates small effect.  ES of 0.3-0.5 is moderate effect, ES>0.5 











Fig 4.1.1: Images of microglia in the NAc following immunoreaction with Iba1 antibody in PND 
45 rat brain sagittal sections 24-hours following 10 once-daily periadolescent injection schedule.  
Panels A-C show vehicle (Veh) treatment, D-F show nicotine (Nic) treatment, G-I show 
minocycline (Min) treatment, and J-L show minocycline 30 minutes prior to nicotine (Nic + 
Min).  200 X magnification images for each treatment are represented by insets in panels A, D, 
G, and J.  Arrows indicate microglia displaying activated morphology, arrowheads indicate 
























Fig 4.1.2: Images of microglia in the mPFC following immunoreaction with Iba1 antibody in 
PND 45 rat brain sagittal sections 24 hours following periadolescent injection schedule.  Panels 
A-C show vehicle (Veh) treatment, D-F show nicotine (Nic) treatment, G-I show minocycline 
(Min) treatment, and J-L show minocycline 30 minutes prior to nicotine (Nic + Min).  200 X 
magnification images for each treatment are represented by insets in panels A, D, G, and J.  
Arrows indicate microglia displaying activated morphology, arrowheads indicate ramified 




























Fig 4.1.3: Images of FosB-ir neurons in the NAc following immunoreaction with FosB antibody 
in PND 45 rat brain sagittal sections 24 hours following periadolescent injection schedule.  
Panels A-C show vehicle (Veh) treatment, D-F show nicotine (Nic) treatment, G-I show 
minocycline (Min) treatment, and J-L indicate minocycline 30 minutes prior to nicotine (Nic + 
Min).  100 X magnification images for each treatment are represented by insets in panels A, D, 


























Fig 4.1.4: Images of FosB-ir neurons in the mPFC following immunoreaction with FosB 
antibody in PND 45 rat brain sagittal sections 24-hours following periadolescent injection 
schedule.  Panels A-C show vehicle (Veh) treatment, D-F show nicotine (Nic) treatment, G-I 
show minocycline (Min) treatment, and J-L show minocycline 30 minutes prior to nicotine (Nic 
+ Min).  100 X magnification images for each treatment are represented by insets in panels A, D, 





























Fig 4.1.5: Bar graphs representing densities of microglia displaying activated morphology and 
FosB-ir in the NAc and mPFC among the 4 treatment groups at PND 45 following 
periadolescent injection schedule.  Density of microglia displaying activated morphology in the 
NAc (A) and mPFC (B).  Bar graphs in panels (C) and (D) represent densities of FosB-ir neurons 
(Reactive nuclei / mm2) in NAc and mPFC respectively. (* in (A) different from all treatment 
































Fig 4.1.6: Images displaying FosB-ir in the DG of the hippocampus in PND 45 rat brain sagittal 
sections 24-hours following periadolescent treatment schedule. A-D The different treatment 
groups: vehicle, nicotine, minocycline, minocycline 30 minutes prior to nicotine respectively. 
100X magnification.  E Bar graph depicting density of FosB-ir neurons (Reactive nuclei / mm2).  

























































Group Pre-conditioning  Post-Conditioning  
   
Vehicle (11) 36 ± 5.7 47 ± 8.2 
Nicotine (11)  30 ± 4.2 44 ± 8.2 
Minocycline (8) 27 ± 6.7 35 ± 6.1 
Minocycline+Nicotine 
(10) 
23 ± 5.0 40 ± 6.2 
   
   
   














 Fig 4.2.1: Graphs of conditioned place preference showing the time spent (seconds) in the least 
preferred or cocaine-paired chamber at PND 80.  A Time spent in the least preferred chamber 
during pre-condtitioning and post-conditioning [* represents significant difference (p<0.05) 
between pre and post].  B Time difference (pre-conditioning subtracted from post conditioning, 
(* show significant difference from vehicle group).  n=8-11. Mean±SEM. Post hoc analysis 
































Fig 4.3.1: Images of microglia in the NAc following immunoreaction with Iba1 antibody in PND 
80 rat brain sagittal sections following periadolescent injection schedule.  Panels A-C show 
vehicle (Veh) treatment, D-F show nicotine (Nic) treatment, G-I indicate minocycline (Min) 
treatment, and J-L indicate minocycline 30 minutes prior to nicotine (Nic + Min).  200 X 
magnification images for each treatment are represented by insets in panels A, D, G, and J.  
Arrows indicate microglia displaying activated morphology, arrowheads indicate ramified 




























Fig 4.3.2: Images of microglia in the mPFC following immunoreaction with Iba1 antibody in 
PND 80 rat brain sagittal sections following periadolescent injection schedule.  Panels A-C show 
vehicle (Veh) treatment, D-F show nicotine (Nic) treatment, G-I indicate minocycline (Min) 
treatment, and J-L indicate minocycline 30 minutes prior to nicotine (Nic + Min).  200 X 
magnification images for each treatment are represented by insets in panels A, D, G, and J.  
Arrows indicate microglia displaying activated morphology, arrowheads indicate ramified 




























Fig 4.3.3: Images of FosB-ir neurons in the NAc following immunoreaction with FosB antibody 
in PND 80 rat brain sagittal sections following periadolescent injection schedule.  Panels A-B 
show vehicle (Veh) treatment, C-D show nicotine (Nic) treatment, E-F indicate minocycline 
(Min) treatment, and G-H indicate minocycline 30 minutes prior to nicotine (Nic + Min).  100 X 
magnification images for each treatment are represented by insets in panels A, C, E, and G.  
























Fig 4.3.4: Images of FosB-ir neurons in the mPFC following immunoreaction with FosB 
antibody in PND 80 rat brain sagittal sections following periadolescent injection schedule.  
Panels A-B show vehicle (Veh) treatment, C-D show nicotine (Nic) treatment, E-F show 
minocycline (Min) treatment, and G-H show minocycline 30 minutes prior to nicotine (Nic + 
Min).  100 X magnification images for each treatment are represented by insets in panels A, C, E 























Fig 4.3.5. Bar graphs representing densities of microglia displaying activated morphology and 
FosB-ir in the NAc and mPFC among the 4 treatment groups at PND 80 following 
periadolescent injection schedule.  Bar graphs in panels (C) and (D) represent densities of FosB-
ir neurons in NAc and mPFC respectively between the 4 treatment groups.  (* in (A and B) 
different from minocycline (MIN) group (p<0.05, Dunnett’s t-test), * in (D) different from 






























Fig 4.3.6. Images of FosB-ir neurons in the DG of the hippocampus in PND 80 rat brain sagittal 
sections following 10 once-daily periadolescent treatment schedule.  A-D The different treatment 
groups: vehicle, nicotine, minocycline, minocycline 30 minutes prior to nicotine respectively.  E 
Bar graph depicting relative densities of FosB-ir neurons among the 4 treatment groups.  (No 

































Fig 4.3.7: Bar graphs depicting total density of microglia in NAc and mPFC among the 4 



































Ch 5. Discussion 
5.1.  Purpose of Dissertation 
The purpose of this dissertation study was to investigate the role of inflammatory 
microglia in the process of nicotine priming of the brain that makes the brain more susceptible to 
cross sensitization to other drugs of abuse, particularly at adulthood.  To achieve this, we sought 
to address 3 specific aims (SA).  The purpose of SA 1 was to investigate changes in the 
expression patterns of the transcription factor FosB in select areas of the rat brain associated with 
drug-reward and memory 24 hours following a 10-day schedule of once-daily injections marking 
the onset of adolescence (PND 35-44).  ∆FosB, the spliced isoform of FosB, is often referred to 
as a ‘sustained molecular switch for addiction’ (Nestler et al. 2001), thus making FosB a suitable 
protein target for investigating molecular changes in the brain pertaining to sensitization, an 
‘important first step’ leading to addiction (Vanderschuren and Pierce 2010).  In this study, the rat 
model system was utilized for testing the molecular and behavioral effects of microglia on the 
sensitization process, as several studies suggest that microglia may play a crucial role in 
mediating sensitization and processes involved with addiction such as relapse arising from 
exposure to drugs of abuse during early adolescence (Chen et al. 2009, Schwarz and Bilbo 2013).  
For this purpose, subject animals were segregated into 4 groups, namely vehicle, 0.4 mg/kg 
nicotine, 30 mg/kg minocycline, or 30 mg/kg minocycline 30 minutes prior to each dose of 
nicotine.  Minocycline, the brain-permeable tetracycline antibiotic was used to suppress the pro-
inflammatory (M1) activation of microglia (Kobayashi et al. 2013).  SA 2 and 3 sought to 
investigate the impact of these periadolescent treatments at adulthood (PND 80), when the brains 
of rats are supposedly fully developed.  The effect of these treatments on rats’ receptivity to 





displaying activated morphology were assessed by immunohistochemistry (IHC) similar to SA1 
(SA 3).   
5.2.A.  Previous studies vs present study 
Previous reports involving rats indicate that priming with nicotine during a specific 
ontological window, namely the onset of adolescence or periadolescence, is crucial in 
establishing brain-sensitization that is conducive to enhanced reward motivation toward drugs of 
abuse that is sustained into adulthood (McMillen et al. 2005, James-Walke et. al. 2007, Adriani 
et al. 2003).  Studies that utilized operant conditioning or CPP indicate that rats were more 
anticipatory towards the rewarding effects of submaximal doses of psychoactive substances like 
nicotine, cocaine, and diazepam when they were primed with nicotine at early adolescence as 
opposed to later life, an indication that sensitization had developed (Adriani et al. 2003, 
McMillen et al. 2005, James-Walke et al. 2007).  The explanation for this observation, as well as 
the mechanisms that give rise to this effect were not comprehensively addressed, although one 
previous study indicated that nicotine exposure at adolescence was able to enhance FosB 
expression by the inhibition of histone deacetylases to enhance reward sensitivity to cocaine 
challenge at adulthood (Levine et al. 2011).  
 Previous studies that investigated molecular mechanisms to explain the establishment of 
a drug-sensitized brain have uncovered several target candidates that may contribute to this end.  
Nicotinic receptors appear to be the most obvious candidate in initiating nicotine-induced reward 
sensitization.  Several nicotinic receptor (NAChR) subunits are upregulated in the VTA of the 
brains of adult rats when the rats were exposed to nicotine during early adolescence (Adriani et 
al. 2003).  Another target candidate to receive recent attention is the IEG transcription factor 





with addiction liability (Soderstrom et al. 2007, Perrotti et al. 2008).  FosB is short-lived 
compared to ∆FosB that activates downstream genes that effectively regulate dopaminergic (DA) 
signaling that mediates reward and sensitization (Nestler et al. 2001).  Enhanced FosB 
immunoreactivity (FosB-ir) is achieved in brain areas associated with reward and reward-
associated memory not only when rats are exposed to nicotine during the onset of adolescence, 
but also when nicotine priming occurs at late/post adolescence (PND 60-69) (Soderstrom et al. 
2007).  Since enhanced cross-sensitization to other drugs of abuse in the adult is a key feature of 
nicotine priming during the onset of adolescence (Adriani et al. 2003, McMillen et al. 2005), the 
observed increase in FosB from late adolescent exposure weakens the causal link between FosB 
induction and the sensitization observed during adult testing.  This effect was further highlighted 
when adult rats showed reduced responsiveness to cocaine or diazepam when primed with 
nicotine during late adolescence (Nestler et al. 2001, McMillen et al. 2005, James-Walke et al. 
2007).  Thus, investigation of other mediators that promote this temporal aspect of nicotine-
induced reward-sensitization is warranted.   
5.2.B.  M1 activation of microglia had impact on FosB, but did not contribute towards 
sensitization 
 In this dissertation study, the contribution of microglia in mediating periadolescent 
nicotine-induced sensitization of the brain was examined as microglia are known to play an 
active role in brain plasticity along with circuit remodeling during adolescence (Paolicelli et al. 
2017).  Furthermore, microglia are responsive to the hormonal changes in the brain that are 
expected in adolescent males (Harry and Kraft 2012) and respond to drugs of abuse from various 
categories that include alcohol, opioids, and other stimulants that exert their rewarding effects by 





morphine exposure induces microglia to shift morphology toward an activated phenotype, with 
activation of pattern recognition receptors (PRRs) such as Toll-Like Receptors (TLRs) on 
microglia (Schwarz and Bilbo 2013, McClain et al. 2011, Crews et al. 2017).  Interestingly, no 
studies to our knowledge have investigated microglia’s role in periadolescent nicotine-induced 
sustained reward sensitization.  It should also be noted that microglia express receptors sensitive 
to hormones and other neurotransmitters pertaining to sensitization such as dopamine and 
estrogens (Färber et al. 2005, Nissen et al. 2017).   
 In this study, it was observed that nicotine exposure once daily for 10 days at 0.4 mg/kg 
during the onset of adolescence increased FosB-ir in the NAc, mPFC, and DG of the 
hippocampus 24 hours following the final set of injections.  This result was in harmony with the 
report by Soderstrom and colleagues (2007).  In the present study, the increase in FosB-ir in the 
NAc was less pronounced than that reported by Soderstrom and colleagues (2007), however an 
increasing trend was evident for the nicotine treatment group, when compared to vehicle (Fig 
4.1.5 C).  To accompany the increase in FosB-ir with nicotine treatment, a statistically 
significant increase was also observed in the density of microglia displaying an ‘activated’ 
morphology, implying a positive correlation between microglia activation and FosB-ir.  The 
same trend held in the mPFC, where nicotine enhanced the shift in microglia morphology from 
ramified to a more activated morphology (Fig 4.1.3 D-F, 4.1.5 B).  This was expected as other 
drugs with abuse liability such as alcohol and opioids encourage microglia polarization that is 
pro-inflammatory (McClain et al. 2011, Schwarz and Bilbo 2013).  
Several in vitro studies with isolated microglia indicate that nicotine has an anti-
inflammatory effect when the microglia are challenged with lipopolysaccharide (LPS) that 





Williamson et al. 2011).  To our knowledge, there are no studies that demonstrate the activation 
of microglia in response to nicotine in the context of psychoactive drug-induced reward 
sensitization.  Here we report an increase in the density of microglia displaying activated 
morphology in the NAc and mPFC following 10 days of once-daily nicotine treatment during 
periadolescence.  Since minocycline is a selective inhibitor of the pro-inflammatory (M1-
polarized) microglia, it would be expected that minocycline pretreatment would attenuate this 
polarization if nicotine induced a shift to the pro-inflammatory phenotype in vivo (Kobayashi et 
al. 2013).  During periadolescent testing at PND 45, in the NAc, the minocycline pretreatment 
reduced the density of Iba1-immunoreactive (Iba1-ir) microglia that displayed the activated 
morphology significantly.  Furthermore, this result suggests that nicotine promotes the shifting of 
microglia towards the M1 state.  Minocycline pretreatment however did not result in a reduction 
in FosB-ir in the NAc as originally hypothesized, thus weakening the causal link between 
increased M1-polarized microglia and elevation in FosB-ir.  Effect size calculations further 
suggest that inflammatory microglia activation has a trivial impact on the induction of FosB-ir 
neurons in the NAc at PND 45 by daily nicotine exposure during the key periadolescent window.    
In the mPFC similar patterns emerged between the minocycline pretreatment and nicotine 
groups, with the exception that the density of FosB-ir neurons is more attenuated in the mPFC in 
the minocycline pretreatment group.  Although this difference is not statistically significant, an 
effect size of 0.77 suggests that there could be a difference detected if the sample sizes were 
expanded.  In the DG, on the other hand, there was an attenuation in FosB-ir neuronal density in 
the granular layer with minocycline pretreatment compared to the nicotine group.  This was an 
interesting finding as the presence of microglia in the DG is sparser and less uniform when 





layers of the DG and make tactile contact with synapses and neurons in the granular layer.  
Although spatial memory tests were not performed in this dissertation study, the reduction in 
FosB-ir in the DG could have an impact on memory as fluctuations in ∆FosB expression in the 
DG is demonstrated to affect memory consolidation in rodents (Eagle et al. 2015).   
5.2.C.  Periadolescent inhibition of inflammatory microglia and consequences at adulthood 
 To understand the long-term consequences of inflammatory microglia activation during 
periadolescent nicotine exposure, changes in FosB-ir and microglia activity were tested at 
adulthood.  Since FosB-ir is sustained into adulthood in the brains of rats exposed to nicotine 
during periadolescence (Soderstrom et al. 2007), we suspected that neuronal expression of FosB 
and microglia activity in brain areas associated with reward and memory could be impacted if 
microglia activation during early adolescence due to nicotine had any long-term consequences.  
Some of the results observed during periadolescence (PND 45) were reversed at the onset of 
adulthood (PND 80).  We initially expected that during adulthood, the densities of microglia 
displaying activated morphology may reverse due to clearance of minocycline following 35 
days, and an increase in microglia proliferation over time.  Although our study did not use a 
maximal or toxic dose of minocycline, it is possible that minocycline prevented proliferation of 
new-born microglia that retained an activated morphology similar to that reported in a binge 
alcohol study (McClain et al. 2011), thus leading to a sustained reduction in activated microglia 
in the minocycline pretreatment group over time (Fig 4.3.5 A, B).  In harmony with this 
suggestion, the minocycline-only group resulted in reduced density of activated microglia in both 
the NAc and mPFC at PND 80 when compared to vehicle, which implies that minocycline is 
inhibiting the normal progress of microglia to an activated morphology from periadolescence to 





brains, we observe that the difference in FosB-ir between nicotine and vehicle follows the same 
pattern as that of PND 45 in both the NAc and mPFC (Fig. 4.3.5 C, D) reflecting the report by 
Soderstrom and colleagues (2007).  In the mPFC, both during PND 45 and PND 80, there were 
reductions in FosB-ir with the minocycline pretreatment, whereas at adulthood, the difference 
reached statistical significance (Fig. 4.3.5 D) giving the impression that the link between 
microglia and FosB with periadolescent nicotine exposure is greater and longer lasting in the 
mPFC than in the NAc.  The link between microglia activation and FosB expression in neurons 
remains unclear but there are mediators that allow microglia to influence neuronal FosB activity.  
Microglia secrete moderate levels of glial-derived neurotrophic factor (GDNF), and with M1 
activation of microglia, as observed with nicotine in this study, the level of GDNF decreases 
further.  Reduced GDNF secretion is associated with increased DA signaling and ∆FosB 
expression (Airavaara et al. 2004).  With minocycline pretreatment, GDNF signaling is expected 
to not be increased, thus possibly resulting in a lack of change in FosB-ir (NAc), or an 
attenuation (mPFC) at most.  The NAc is the brain nuclei most often associated with drug 
seeking or incentive salience, and DA functioning in the NAc is implicated in CPP preference 
(Prus et al. 2009).  Thus, the lack of significant change in FosB observed in the NAc both during 
PND 45 and 80, could be the reason for the lack of change observed in motivation for cocaine as 
observed with CPP testing.  
Following the transition from periadolescence to adulthood, the magnitude of the differences in 
densities of activated microglia between the vehicle and nicotine groups are attenuated to the 
point where the difference was no longer statistically significant at PND 80, indicating that 
nicotine may not have had a long-lasting effect on keeping microglia in an activated state, or that 





phenomenon that is common with aging in adult rats (Lynch 2009).  A significant difference was 
only present between the nicotine and minocycline-only groups.  Furthermore, it was noted that 
overall microglia density in the minocycline-only group was significantly reduced compared to 
the nicotine group.  This was interesting, as it appears that minocycline discouraged microglia 
proliferation which may have manifested as lower microglia density at adulthood.  In the 
minocycline pretreatment group, nicotine appears to have promoted microglia proliferation or 
stability, whereas minocycline by itself discouraged microglia proliferation in the long term (Fig. 
4.3.5 A, B; 4.3.7 A, B).  The results from the CPP experiments were interesting, in that 
minocycline pretreatment prior to each nicotine exposure during periadolescence failed to inhibit 
anticipation for cocaine as initially hypothesized due to the enhanced sensitization from 
periadolescent nicotine (Fig 4.2.1).  Submaximal doses of cocaine were used to test sensitization 
in this study as cocaine is a CNS stimulant that has its rewarding actions mediated via 
mesolimbic reward pathway and is commonly used in studies investigating reward sensitization 
(McMillen et al. 2005).  Furthermore, nicotine priming in mice prior to cocaine enhances CPP 
for cocaine as well as locomotor responsiveness possibly through inhibition of histone 
deacetylase activity (Levine et al. 2011).  The important caveat in our study compared to other 
studies testing for locomotor responsivity to cocaine challenge such as that by Chen and 
colleagues (2009) is that the animals in this study were not subjected to the test drug on the day 
of testing.  Twenty-four hours following final vehicle injection, rats were placed back into the 
CPP apparatus for 15 minutes and chamber preference and entries were determined.  Also, prior 
to conditioning the rats displayed similar baseline preferences for the chamber that was to be 
paired with cocaine among all the 4 groups (Fig. 4.2.1 A), indicating that the different exposures 





expected, the periadolescent nicotine treatment group did show increased responsiveness, in this 
case seeking behavior, to cocaine as compared to vehicle in harmony with previous studies 
(McMillen et al. 2005).  The minocycline-only treatment group showed a trend similar to 
vehicle, indicating that suppression of M1 microglia by minocycline at the onset of adolescence 
did not have an impact on the rats’ responsivity to cocaine at adulthood, neither an increase nor 
an inhibition of response, which in itself is an interesting find.  Minocycline pretreatment to 
nicotine at periadolescence did not alter nicotine’s ability to enhance response for cocaine, and 
the rats thus exhibited a response for the cocaine-paired chamber similar to that of the nicotine 
group.  This result suggests that M1 polarization of microglia during periadolescence, when 
nicotine exerts its sensitizing effect, does not appear to be the cause for nicotine’s ability to 
sensitize the brain to the rewarding effects of cocaine.  Although, this study did not measure the 
expression levels of cytokines characteristic of M1 polarization such as 1L-1ß, TNF-alpha, or 
certain TLRs, staining with antibodies selective for Iba1 during periadolescence revealed fewer 
microglia displaying morphology characteristic of activation both during periadolescence and 
adulthood (Fig 4.1.5; 4.3.5).  This reduction in the density of microglia displaying an activated 
morphology indicates that the dose of minocycline (30 mg/kg) used was effective towards this 
purpose.     
Place preference in the CPP paradigm is typically attributed to enhanced DA signaling 
stimulated by the rewarding substance (Prus et al. 2009).  In this study, we observed that the 
difference in density of microglia displaying the activated morphology between the minocycline 
pretreatment group and the nicotine group at PND 80 was reversed compared to PND 45.  This 
suggests that the effects of the minocycline pretreatment were dissipating with age.  





subject.  This could explain why at adulthood no changes in cocaine seeking were observed with 
CPP testing.  If a reduction in preference for cocaine was accompanied with reduced FosB-ir at 
adulthood from the periadolescent minocycline pretreatment, then it could be implied that both 
FosB and M1 activation of microglia contribute to sensitization at adulthood in the rats 
previously primed with nicotine.  This however was not the case, as our data indicate that neither 
FosB-ir in the NAc nor cocaine seeking were hindered with minocycline pretreatment at the 
onset of adolescence, thus making a case that neither FosB-ir, nor inflammatory microglia are 
involved in mediating the sensitization that is observed with periadolescent nicotine exposure.   
This study also investigated the impact of microglia on FosB-ir in the mPFC, as the NAc 
is increasingly regulated by neurotransmission from the mPFC as the subject ages.  As discussed 
in Chapter 2, the DA system is less mature during adolescence, but as the subject ages, the 
connections between NAc and mPFC become more integrated.  This leads to the possibility that 
nicotine, during early adolescence, via expression and accumulation of ∆FosB may cause long-
lasting changes in DA neurotransmission in the NAc that is not possible with late adolescent or 
adult exposure, in other words, a synergistic link between DA and ∆FosB that is temporally 
dependent.  In this study, we demonstrated that at PND 45, minocycline pretreatment did not 
significantly reduce FosB-ir compared to the nicotine group in the mPFC, but at adulthood, the 
reduction in FosB-ir becomes significant with the minocycline pretreatment, which implies that 
minocycline may have a more time-dependent impact on FosB-ir in the mPFC as compared to 
the NAc.  Furthermore, this correlated with a reduction in density of microglia with activated 
morphology that almost reached statistical significance on comparison with nicotine group (Fig. 
4.3.5 B).  FosB gene products activate the transcription factor cdk5 that phosphorylates DARPP-





effect of many drugs of abuse such as cocaine, amphetamine, and nicotine (Svenningsson et al. 
2005).  In our study, at PND 45, there was no significant reduction in FosB-ir in the NAc or 
mPFC between nicotine and minocycline pretreatment, although at adulthood the difference 
became more pronounced in the mPFC.   
The lack of change in FosB-ir in the NAc observed during adulthood (Fig. 4.3.5 C) in the 
minocycline pretreatment group is expected to translate to a lack of substantial change in 
phosphorylation of DARPP32 in the NAc, as DARPP32 is downstream of FosB (Norrholm et al. 
2003).  This could further explain why the cocaine seeking behavior during adult testing was 
similar to the nicotine group.  Even though nicotine is a stimulant similar to several varieties of 
drugs with abuse liability, studies with nicotine as a priming substance is expected to yield 
results different from other drugs with abuse liability such as cocaine, amphetamines, morphine, 
and alcohol as different drugs act on their targets differently.  Most drugs of abuse enhance 
reward sensitivity via the mesocorticolimbic reward pathway that includes the VTA and NAc 
with inputs from other nuclei such as the hippocampus and mPFC.  Unlike other drugs with 
abuse liability such as THC and opiates that stimulate G-coupled receptors on medium spiny 
neurons (MSN) of the NAc, nicotine activates the nicotinic receptors on VTA glutamatergic 
inputs to open ligand-operated ion channels that effectively enhance extracellular DA in the NAc 
and at the post-synaptic neurons (Pierce and Kumaresan 2006).  The pulsatile flow of DA into 
the NAc due to exposure to low or high concentrations of nicotine also plays a critical role in 
nicotine self-administration and CPP.  DA’s actions on NAc DA receptors can vary greatly with 
the dose of nicotine (high vs low), with higher nicotine concentrations being conducive to 
increased self-administration and CPP (Laviolette and van der Kooy 2004).  How nicotine and 





periadolescent nicotine exposure needs to be further explored.  In this study, we demonstrated 
that inflammatory microglia polarization due to nicotine during a small window marking the 
onset of adolescence, does not contribute to enhancing the rat’s sensitivity to cocaine at 
adulthood.  Rather than simply testing for behavioral sensitization, we further demonstrated that 
in the NAc, pretreatment with minocycline did not alter nicotine’s ability to enhance FosB, an 
IEG transcription factor whose truncated isoform is referred to as ‘a sustained molecular switch 
for addiction’ (Nestler et al. 2001).   
Nicotine and microglia function differently based on the physiological or pathological 
context of nicotine acting on microglia.  Studies in Parkinson’s disease as well as other 
neuroinflammatory models suggest that nicotine plays an anti-inflammatory role by engaging -
7 nicotinic receptors on microglia and inhibiting the actions of microglial proton currents 
mediated by NADPH oxidase (Noda and Kobayashi 2017).  Neuroinflammatory diseases related 
to aging are contextually different from that of microglia mediating the gateway actions of 
psychoactive drugs.  Our study indicates that nicotine during periadolescence promotes 
inflammatory microglia activation in the NAc and mPFC that is sustained into adulthood in the 
context of nicotine-induced reward sensitization.  The role of inflammatory microglia in 
mediating altered DA neurotransmission in the context of drug reinforcement is unclear, 
although studies suggest that inflammatory microglia are involved in morphine reinstatement in 
rats and mediation of locomotor sensitization from chronic cocaine exposure in mice following 
cocaine stimulation, both being processes that involve DA neurotransmission (Schwarz and 
Bilbo 2013, Chen et al. 2009, Prus et al. 2009).  The context in which microglia are stimulated is 
also key in the extent that minocycline would influence reward perception.  In a chronic pain 





further inhibited DA neurotransmission by opiates in the NAc, minocycline reversed the 
attenuation of DA neurotransmission leading to an amelioration of reward perception and mood 
(Taylor et al. 2015).  Our study indicated that minocycline pretreatment prior to nicotine at 
periadolescence did not inhibit the desire for cocaine in the adult rat via minocycline’s action on 
inflammatory microglia.  However, in our study the testing with cocaine was more than 35 days 
removed from the last dose of minocycline, thus rendering our study difficult for comparison 
with results from others.   
Results from the minocycline pretreatment group at PND 80 indicate that microglia revert 
to the activated morphology following maturation into adulthood.  To expand upon the role of 
microglia at adulthood in promoting sensitization, treatment with minocycline at adulthood prior 
to cocaine conditioning would indicate if adult microglia are inducing sensitization or facilitating 
the enhanced response to cocaine during conditioning.  Also, to understand microglia’s effect on 
dopamine neurotransmission, certain nicotinic receptor subunits such as the ß2 subunit in the 
VTA, along with dopamine transporter (DAT) in the NAc, can be probed both during 
periadolescence and adulthood.  Alternatively, extracellular DA concentration in the NAc can be 
measured using microdialysis.  
5.3. Conclusions. 
Although this study did observe an increase in microglia displaying the activated 
morphology (putatively M1 polarized microglia) due to nicotine exposure at periadolescence, we 
did not attempt to measure changes in the levels of inflammatory-cytokines typical of microglial 
activation cascades.  Additionally, expression levels of microglial PAMPs such as TLRs along 
with cytokines characteristic of M1 polarization could be useful biomarkers for assessing the 





The aim of this study was to extend the current knowledge of the age-related Gateway 
effect of nicotine.  The reasons behind the observation that nicotine priming at the onset of 
adolescence enhances sensitivity to drugs of abuse from different categories at adulthood 
remains a mystery.  This study contributed toward solving that mystery by investigating if 
inflammatory microglia, because of nicotine exposure at periadolescence, play a role in this 
process.  To test for this, minocycline was used to suppress the inflammatory activation of 
microglia during periadolescent nicotine exposure, and molecular and behavioral effects were 
assessed by measuring changes in FosB-ir in brain areas relevant to drug-reward and memory, 
along with CPP to the test responsiveness to cocaine at adulthood.   
Several novel findings emerged from this study.  The daily injections of nicotine resulted 
in an increase of M1 type polarization of microglia.  Minocycline did prevent nicotine’s ability to 
activate microglia and this effect further persisted into adulthood, although the differences 
between nicotine and minocycline pretreatment groups were not as robust at adulthood.  
Minocycline pretreatment did have a variable effect on expression of FosB-ir at the molecular 
level, but at the behavior level, minocycline pretreatment did not prevent the sensitization to 
cocaine as originally hypothesized.  The conclusion is that although there may be an interaction 
between expression of FosB and inflammatory activation of microglia, neither appears to be 
important for nicotine-induced behavioral sensitization in the early adolescent rat.  
Recent National Youth Tobacco Survey results indicate a 10-fold increase in e-cigarettes 
use by middle and high school students between the years 2011-2015 (Singh et al. 2016).  The 
results obtained from our study suggest that nicotine use during early adolescence, when youth 
are attending middle and high school, will result in a neuroinflammatory response in the brains 





associated with inflammation is not adequate in attenuating preference and responsiveness to 
other drugs with abuse potential in the future.  Thus, it is best if exposure to nicotine-laced 
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